2-ACYLAMINOPROPANOL-TYPE GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

PROBLEM TO BE SOLVED: To provide 2-acylaminopropanol-type glucosylceramide synthase inhibitors.SOLUTION: The present invention provides a pharmaceutical composition for treating polycystic kidney disease, comprising a compound represented by one of predetermined structural formulas or a pharmaceutic...

Full description

Saved in:
Bibliographic Details
Main Authors JOHN KANE, XIANG YIBIN, ANGELES DIOS, RICHARD SILVA, MIKAELA LEVINE, LISA M CUFF, JUNKAI LIAO, EDWARD LEE, CASSANDRA A CELATKA, SIEGEL CRAIG, BASTOS CECILIA M, DAVID J HARRIS, FREDERIC VINICK, THOMAS H JOZAFIAK
Format Patent
LanguageEnglish
Japanese
Published 03.08.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide 2-acylaminopropanol-type glucosylceramide synthase inhibitors.SOLUTION: The present invention provides a pharmaceutical composition for treating polycystic kidney disease, comprising a compound represented by one of predetermined structural formulas or a pharmaceutically acceptable salt thereof.SELECTED DRAWING: None 【課題】2−アシルアミノプロパノール−タイプグルコシルセラミドシンターゼ抑制剤を提供すること。【解決手段】所定の構造式の1つによって表される化合物、またはその薬学的に許容可能な塩を含む、多発性嚢胞腎疾患の治療のための医薬組成物。【選択図】なし
Bibliography:Application Number: JP20170095022